Stryker, Johnson & Johnson and Zimmer Biomet posted their second quarter financial results for 2023, and data on their orthopedic sales.
Here is how they compare:
Total sales: $5 billion (+11.2 percent)
Orthopedics and spine: $2.1 billion (+9.9 percent)
Hips: $393 million (+8.1 percent)
Knees: $562 million (+12.5 percent)
Spine: $296 million (+1.8 percent)
Total sales: $25.5 billion (+6.3 percent)
Spine, sports and other: $766 million (+5.8 percent)
Orthopedic: $2.3 billion (+5 percent)
Hips: $397 million (+2.2 percent)
Knees: $363 million (+3.9 percent)
Total sales: $1.8 billion (+4.9 percent)
Hips: $504.3 million (+3.5 percent)
Knees: $771.4 million (+9.4 percent)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $442.7 (-0.8 percent)